1. Home
  2. BDTX vs EJH Comparison

BDTX vs EJH Comparison

Compare BDTX & EJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

N/A

Current Price

$1.38

Market Cap

104.0M

Sector

Health Care

ML Signal

N/A

Logo E-Home Household Service Holdings Limited

EJH

E-Home Household Service Holdings Limited

N/A

Current Price

$1.10

Market Cap

85.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
BDTX
EJH
Founded
2014
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
85.1M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
BDTX
EJH
Price
$1.38
$1.10
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $11.00
N/A
AVG Volume (30 Days)
★ 766.3K
7.1K
Earning Date
11-10-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 130.71
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.08
52 Week High
$3.97
$3.07

Technical Indicators

Market Signals
Indicator
BDTX
EJH
Relative Strength Index (RSI) 34.73 43.91
Support Level N/A $0.08
Resistance Level $1.94 $1.43
Average True Range (ATR) 0.14 0.15
MACD -0.04 -0.01
Stochastic Oscillator 0.84 27.16

Price Performance

Historical Comparison
BDTX
EJH

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

About EJH E-Home Household Service Holdings Limited

E-Home Household Service Holdings Ltd is a household service. It operate business mainly by receiving orders online and providing the services offline. It has three reportable segments installation and maintenance services, housekeeping services and senior care services. Majority of revenue comes from Installation and maintenance segment.

Share on Social Networks: